Pancreatic Cancer Research

ResearcherJikei University School of MedicineActive in the last 2 years

Mitsuru Yanagaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0664-5830; OpenAlex author ID A5064216654. Sources: OpenAlex.

Their work

Papers
15
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 4 papers · 2026: 5 papers

Papers 15

  1. Number of Liver Metastases Stratifies Prognosis in Synchronous Metastatic Pancreatic Cancer. Co-author DOI 10.1002/wjs.70666↗
  2. The Goddard score for emphysema predicts the postoperative prognosis in pancreatic cancer. Co-author DOI 10.1007/s00595-025-03188-7↗
  3. Prognostic stratification of unresectable locally advanced pancreatic cancer using a combination of inflammatory and nutritional indices: a retrospective cohor… Co-author DOI 10.1007/s00595-026-03344-7↗
  4. Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20340-w↗
  5. ASO Visual Abstract: Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20399-5↗
  6. Abdominal aortic calcification volume as a preoperative prognostic predictor for pancreatic cancer. Co-author DOI 10.1007/s00595-024-02882-2↗
  7. The minimum apparent diffusion coefficient value on preoperative magnetic resonance imaging in resectable pancreatic cancer: a new prognostic factor for biolog… Co-author DOI 10.1007/s00595-025-03050-w↗
  8. Signal heterogeneity in apparent diffusion coefficient map of magnetic resonance imaging in resectable pancreatic cancer: a new prognostic factor for biologica… Co-author DOI 10.1016/j.suronc.2025.102270↗
  9. The Significant Impact of Fibrinogen-C-Reactive Protein-Albumin Ratio on the Long-Term Outcomes After Pancreatic Resection for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002416↗
  10. Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00423-024-03315-x↗
  11. Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer. Co-author DOI 10.1016/j.suronc.2023.101998↗
  12. The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/00031348231204912↗
  13. Inhibition of lysosomal acid β-glucosidase induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer. Co-author DOI 10.1093/carcin/bgac060↗
  14. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer. Co-author DOI 10.1007/s10147-021-01964-2↗
  15. Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells. Co-author DOI 10.1111/cas.15123↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toru Ikegami · 15 shared papers, 2021–2026 · strength 3.26
  2. Yoshihiro Shirai · 15 shared papers, 2021–2026 · strength 3.26
  3. Koichiro Haruki · 14 shared papers, 2021–2026 · strength 3.08
  4. Kenei Furukawa · 14 shared papers, 2021–2026 · strength 3.05
  5. Shinji Onda · 10 shared papers, 2021–2026 · strength 2.20
  6. Tomohiko Taniai · 10 shared papers, 2021–2026 · strength 2.09
  7. Masashi Tsunematsu · 8 shared papers, 2023–2026 · strength 1.89
  8. Michinori Matsumoto · 7 shared papers, 2023–2026 · strength 1.56
  9. Yoshiaki Tanji · 6 shared papers, 2023–2026 · strength 1.34
  10. Ryoga Hamura · 7 shared papers, 2021–2026 · strength 1.19
  11. Yosuke Igarashi · 5 shared papers, 2023–2026 · strength 1.17
  12. Takeshi Gocho · 5 shared papers, 2021–2026 · strength 1.02
  13. Tadashi Uwagawa · 5 shared papers, 2021–2026 · strength 0.92
  14. Taro Sakamoto · 3 shared papers, 2023–2025 · strength 0.61
  15. Yuta Yamada · 2 shared papers, 2025–2026 · strength 0.53
  16. Norimitsu Okui · 2 shared papers, 2024–2025 · strength 0.45
  17. Kyohei Abe · 2 shared papers, 2023 · strength 0.32
  18. Takashi Horiuchi · 2 shared papers, 2021–2022 · strength 0.25
  19. Tadashi Uwagawa · 1 shared paper, 2025 · strength 0.25
  20. Hiroaki Shiba · 1 shared paper, 2021 · strength 0.12
  21. Shinji Tanaka · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.